The Latest Breaking News from Novo Nordisk

A global shortage means some people with diabetes are struggling to access the drug semaglutide, which is sold under the brand name Ozempic.

It will also look at one used to for type 2 diabetes

Eli Lilly stock surged closer to a record high Tuesday after the company set a new bar in the industry for weight-loss medications.

Pfizer stock toppled Monday after the company tossed out a potential diabetes and weight-loss drug that leads to elevated liver enzymes.

Losing significant amounts of weight may soon be as easy as taking a daily pill

Novo Nordisk is investing in obesity prevention, the 'real big frontier' of weight loss.

Custom-made versions of Ozempic are hitting the weight loss and that could be thinning out Novo Nordisk's profits.

Diabetes is a growing concern as more of the globe becomes modernized and with that is eating a diet that too often is a road to diabetes. Gladly there are drug companies at the forefront of this movement to stem the tide like Novo Nordisk (NVO) making it a very…

A few years ago, celebrity weight-control practices were out of most people’s reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for most. But with the advent of drugs such as semaglutide, it seems that anyone can go…